Manufacturers Life Insurance Company, The Phathom Pharmaceuticals, Inc. Transaction History

Manufacturers Life Insurance Company, The

$100 Billion
Q1 2025

A detailed history of Manufacturers Life Insurance Company, The transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 14,462 shares of PHAT stock, worth $142,306. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,462

Previous 13,990 3.37%

Holding current value

$142,306

Previous $113,000 20.35%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$4.22 - $7.74 $1,991 - $3,653	472 Added 3.37%	14,462 $90,000
Q4 2024 Feb 14, 2025	BUY	$7.45 - $18.94 $2,950 - $7,500	396 Added 2.91%	13,990 $113,000
Q3 2024 Nov 13, 2024	SELL	$10.25 - $19.5 $3,556 - $6,766	-347 Reduced 2.49%	13,594 $245,000
Q2 2024 Aug 14, 2024	BUY	$8.97 - $12.05 $12,010 - $16,134	1,339 Added 10.63%	13,941 $143,000
Q1 2024 May 14, 2024	BUY	$6.21 - $11.05 $2,185 - $3,889	352 Added 2.87%	12,602 $133,000
Q3 2023 Nov 15, 2023	BUY	$10.26 - $15.7 $18,816 - $28,793	1,834 Added 17.61%	12,250 $127,000
Q2 2023 Aug 11, 2023	BUY	$7.28 - $14.32 $2,446 - $4,811	336 Added 3.33%	10,416 $149,000
Q3 2022 Aug 11, 2023	SELL	$6.46 - $12.11 $2,609 - $4,892	-404 Reduced 3.85%	10,080 $111,000
Q3 2022 Nov 03, 2022	SELL	$6.46 - $12.11 $2,609 - $4,892	-404 Reduced 3.85%	10,080 $112,000
Q2 2022 Aug 11, 2023	BUY	$6.2 - $15.5 $65,000 - $162,502	10,484 New	10,484 $88,000
Q2 2022 Aug 15, 2022	BUY	$6.2 - $15.5 $65,000 - $162,502	10,484 New	10,484 $88,000
Q1 2022 May 20, 2022	SELL	$11.55 - $20.06 $132,166 - $229,546	-11,443 Closed	0 $0
Q4 2021 Feb 16, 2022	BUY	$17.83 - $33.15 $4,510 - $8,386	253 Added 2.26%	11,443 $225,000
Q3 2021 Nov 12, 2021	SELL	$30.69 - $36.83 $21,452 - $25,744	-699 Reduced 5.88%	11,190 $359,000
Q2 2021 Aug 12, 2021	BUY	$32.66 - $39.87 $155,624 - $189,980	4,765 Added 66.89%	11,889 $402,000
Q1 2021 May 03, 2021	BUY	$33.86 - $48.68 $9,040 - $12,997	267 Added 3.89%	7,124 $268,000
Q4 2020 Feb 12, 2021	BUY	$33.22 - $50.26 $3,753 - $5,679	113 Added 1.68%	6,857 $228,000
Q2 2020 Aug 10, 2020	BUY	$25.06 - $54.6 $169,004 - $368,222	6,744 New	6,744 $227,000

Others Institutions Holding PHAT

# of Institutions

152

Shares Held

66.6M

Call Options Held

94K

Put Options Held

55.5K

View Full List

About Phathom Pharmaceuticals, Inc.

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $385M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

More about PHAT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Phathom Pharmaceuticals, Inc. Transaction History